Related Experiment Video
Updated: May 7, 2026

Sub-acute Cerebral Microhemorrhages Induced by Lipopolysaccharide Injection in Rats
Published on: October 17, 2018
Brain hemorrhages in cerebral amyloid angiopathy
1Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
Insights
Cerebral amyloid angiopathy (CAA) involves amyloid buildup in brain blood vessels, leading to strokes and dementia. Future strategies must protect vessel walls from amyloid damage and develop effective antiamyloid therapies.
Area of Science:
- Neurology
- Pathology
- Vascular Biology
Background:
- Cerebral amyloid angiopathy (CAA) is characterized by amyloid protein deposition in cerebral vasculature.
- Sporadic amyloid β-protein (Aβ)-type CAA is prevalent in elderly individuals and those with Alzheimer disease.
- CAA contributes to cerebrovascular disorders, including stroke and dementia.
Purpose of the Study:
- To review the classification, clinical manifestations, and diagnostic methods for CAA.
- To identify hemorrhage-inducing factors associated with sporadic Aβ-type CAA.
- To discuss future therapeutic strategies for managing CAA and its complications.
Main Methods:
- Review of existing literature on cerebral amyloid angiopathy.
- Analysis of diagnostic imaging techniques, including MRI and PET ligands.
- Identification of risk factors and pathogenic mechanisms contributing to CAA-related hemorrhages.
Main Results:
- CAA is classified by the type of amyloid protein involved, with Aβ-type common in aging and Alzheimer's.
- CAA is linked to various hemorrhages (lobar, microhemorrhages, subarachnoidal) and vasculopathies.
- Risk factors for hemorrhage in Aβ-CAA include genetics (APOE), therapies (anticoagulants), hypertension, and trauma.
Conclusions:
- Advanced MRI and PET imaging aid in detecting CAA and associated microhemorrhages.
- Understanding hemorrhage-inducing factors is crucial for managing patients with CAA.
- Future research should focus on protecting vessel walls and developing targeted antiamyloid therapies for CAA.
Abstract:
Cerebral amyloid angiopathy (CAA) is cerebrovascular amyloid deposition. It is classified into several types according to the cerebrovascular amyloid proteins involved. Sporadic amyloid β-protein (Aβ)-type CAA is commonly found in elderly individuals and patients with Alzheimer disease. CAA-related disorders include hemorrhagic and ischemic stroke and dementia. CAA-related hemorrhages include intracerebral lobar macrohemorrhages, cortical microhemorrhages, and focal subarachnoidal hemorrhages/superficial siderosis. CAA-associated vasculopathies, such as microaneurysmal formation with fibrinoid necrosis, underlie such cerebrovascular events. Sensitive magnetic resonance imaging procedures, such as gradient-echo T2* imaging and susceptibility-weighted images, are useful to detect microhemorrhagic lesions. Amyloid images with amyloid-binding positron emission tomography ligands can detect CAA, although they cannot discriminate vascular from parenchymal amyloid deposits. Hemorrhage-inducing factors for sporadic Aβ-type CAA include apolipoprotein E genotype, thrombolytic, anticoagulation, and antiplatelet therapies, hypertension, minor head trauma, and antiamyloid therapies. We need future strategies for protection of vessel walls against amyloid-related vascular damage, such as toxicity of Aβ oligomers, Aβ-induced oxidative stress, and inflammation, as well as development of antiamyloid therapies for CAA.
More Related Videos
09:31Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
09:14Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
Related Concept Videos
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Cerebral Edema ll: Pathophysiology
Cerebral Edema l: Introduction
Dementia l: Introduction